Anthem Biosciences files draft papers with Sebi for ₹3,395-crore IPO
Anthem Biosciences on Tuesday (December 31, 2024) filed preliminary papers with capital markets regulator Sebi to float a ₹3,395-crore initial public offering. The proposed initial public offer (IPO) is entirely an offer for sale (OFS) worth ₹3,395 crore by promoters, investors and other selling shareholders, according to a Draft Red Herring Prospectus (DRHP). Under the…
Read More “Anthem Biosciences files draft papers with Sebi for ₹3,395-crore IPO” »